202 related articles for article (PubMed ID: 34059639)
1. Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex.
Weir SJ; Dandawate P; Standing D; Bhattacharyya S; Ramamoorthy P; Rangarajan P; Wood R; Brinker AE; Woolbright BL; Tanol M; Ham T; McCulloch W; Dalton M; Reed GA; Baltezor MJ; Jensen RA; Taylor JA; Anant S
Cell Death Dis; 2021 May; 12(6):562. PubMed ID: 34059639
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs.
Weir SJ; Wood R; Schorno K; Brinker AE; Ramamoorthy P; Heppert K; Rajewski L; Tanol M; Ham T; McKenna MJ; McCulloch W; Dalton M; Reed GA; Jensen RA; Baltezor MJ; Anant S; Taylor JA
J Pharmacol Exp Ther; 2019 Aug; 370(2):148-159. PubMed ID: 31113837
[TBL] [Abstract][Full Text] [Related]
3. Reposition of the Fungicide Ciclopirox for Cancer Treatment.
Huang Z; Huang S
Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561
[TBL] [Abstract][Full Text] [Related]
4. Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease.
Radadiya PS; Thornton MM; Puri RV; Yerrathota S; Dinh-Phan J; Magenheimer B; Subramaniam D; Tran PV; Zhu H; Bolisetty S; Calvet JP; Wallace DP; Sharma M
JCI Insight; 2021 Mar; 6(8):. PubMed ID: 33784251
[TBL] [Abstract][Full Text] [Related]
5. Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
Braun JA; Herrmann AL; Blase JI; Frensemeier K; Bulkescher J; Scheffner M; Galy B; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2020 Jan; 146(2):461-474. PubMed ID: 31603527
[TBL] [Abstract][Full Text] [Related]
6. Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal-ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy.
Al-Zubaydi F; Gao D; Kakkar D; Li S; Adler D; Holloway J; Szekely Z; Gu Z; Chan N; Kumar S; Love S; Sinko PJ
J Control Release; 2020 Jul; 323():71-82. PubMed ID: 32302762
[TBL] [Abstract][Full Text] [Related]
7. Ciclopirox targets cellular bioenergetics and activates ER stress to induce apoptosis in non-small cell lung cancer cells.
Lu J; Li Y; Gong S; Wang J; Lu X; Jin Q; Lu B; Chen Q
Cell Commun Signal; 2022 Mar; 20(1):37. PubMed ID: 35331268
[TBL] [Abstract][Full Text] [Related]
8. Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling.
Su Z; Han S; Jin Q; Zhou N; Lu J; Shangguan F; Yu S; Liu Y; Wang L; Lu J; Li Q; Cai L; Wang C; Tian X; Chen L; Zheng W; Lu B
Cell Death Dis; 2021 Mar; 12(3):251. PubMed ID: 33674562
[TBL] [Abstract][Full Text] [Related]
9. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
Eberhard Y; McDermott SP; Wang X; Gronda M; Venugopal A; Wood TE; Hurren R; Datti A; Batey RA; Wrana J; Antholine WE; Dick JE; Schimmer AD
Blood; 2009 Oct; 114(14):3064-73. PubMed ID: 19589922
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer.
Huang YM; Cheng CH; Pan SL; Yang PM; Lin DY; Lee KH
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684108
[TBL] [Abstract][Full Text] [Related]
11. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.
Mihailidou C; Papakotoulas P; Papavassiliou AG; Karamouzis MV
Oncotarget; 2018 Feb; 9(12):10360-10374. PubMed ID: 29535812
[TBL] [Abstract][Full Text] [Related]
12. Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer.
Qi J; Zhou N; Li L; Mo S; Zhou Y; Deng Y; Chen T; Shan C; Chen Q; Lu B
Cell Death Dis; 2020 Jul; 11(7):582. PubMed ID: 32719342
[TBL] [Abstract][Full Text] [Related]
13. Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells.
Chen L; Chen D; Li J; He L; Chen T; Song D; Shan S; Wang J; Lu X; Lu B
Cell Death Dis; 2022 Nov; 13(11):1007. PubMed ID: 36443287
[TBL] [Abstract][Full Text] [Related]
14. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
15. Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy.
Al-Zubaydi F; Gao D; Kakkar D; Li S; Holloway J; Szekely Z; Chan N; Kumar S; Sabaawy HE; Love S; Sinko PJ
Drug Deliv Transl Res; 2022 Jan; 12(1):240-256. PubMed ID: 33590464
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of presenilins attenuates proliferation and invasion in bladder cancer cells through multiple pathways.
Gai JW; Wahafu W; Hsieh YC; Liu M; Zhang L; Li SW; Zhang B; He Q; Guo H; Jin J
Urol Oncol; 2014 Jan; 32(1):36.e19-25. PubMed ID: 23628311
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of the aqueous extract of Magnolia officinalis on the responses of human urinary bladder cancer 5637 cells in vitro and mouse urinary bladder tumors induced by N-Butyl-N-(4-hydroxybutyl) nitrosamine in vivo.
Lee SJ; Cho YH; Park K; Kim EJ; Kang BS; Jung KH; Kim CH; Kim WJ; Moon SK
Phytother Res; 2009 Jan; 23(1):20-7. PubMed ID: 19048611
[TBL] [Abstract][Full Text] [Related]
19. Repositioning the Old Fungicide Ciclopirox for New Medical Uses.
Shen T; Huang S
Curr Pharm Des; 2016; 22(28):4443-50. PubMed ID: 27238364
[TBL] [Abstract][Full Text] [Related]
20. Ciclopirox olamine promotes the angiogenic response of endothelial cells and mesenchymal stem cells.
Kremer A; Wußmann M; Herrmann M; Raghunath M; Walles H
Clin Hemorheol Microcirc; 2019; 73(2):317-328. PubMed ID: 31006674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]